LivoBot Co., Ltd. focuses on the upstream of the life sciences and biopharmaceutical industries. Driven by foundational technologies such as the construction, manipulation, and detection of high-throughput and micro-volume reaction systems, the company addresses the demands for high throughput, multi-omics, automation, and intelligence in advanced detection applications like sequencing, as well as the R&D and production-end needs in cutting-edge fields such as synthetic biology and high-throughput drug screening. It develops specialized tool product lines for niche areas while advancing the engineering and clinical application of life science technologies.
All members of the company's founding team are from leading enterprises in the biopharmaceutical field. With more than ten years of in-depth experience in the instrument and equipment market of life science fields such as nucleic acid, protein and cell detection, they have successful experiences in innovative R&D and industrialization, as well as a profound understanding of the needs of the life science and biopharmaceutical industries.
LivoBot's well-established R&D center is staffed by skilled and professional researchers.
LivoBot's dedicated production team works in well-maintained workshops to deliver quality products.
